FI950016A - Heterosykliset yhdisteet lääkeaineena - Google Patents
Heterosykliset yhdisteet lääkeaineena Download PDFInfo
- Publication number
- FI950016A FI950016A FI950016A FI950016A FI950016A FI 950016 A FI950016 A FI 950016A FI 950016 A FI950016 A FI 950016A FI 950016 A FI950016 A FI 950016A FI 950016 A FI950016 A FI 950016A
- Authority
- FI
- Finland
- Prior art keywords
- group
- substituted
- compound
- alkyl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929214185A GB9214185D0 (en) | 1992-07-03 | 1992-07-03 | Novel compounds |
GB929227030A GB9227030D0 (en) | 1992-12-29 | 1992-12-29 | Novel compounds |
GB939311027A GB9311027D0 (en) | 1993-05-28 | 1993-05-28 | Novel compounds |
PCT/GB1993/001363 WO1994001420A1 (en) | 1992-07-03 | 1993-06-29 | Heterocyclic compounds as pharmaceutical |
Publications (2)
Publication Number | Publication Date |
---|---|
FI950016A0 FI950016A0 (fi) | 1995-01-02 |
FI950016A true FI950016A (fi) | 1995-03-02 |
Family
ID=27266276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI950016A FI950016A (fi) | 1992-07-03 | 1995-01-02 | Heterosykliset yhdisteet lääkeaineena |
Country Status (19)
Country | Link |
---|---|
US (2) | US6048883A (ko) |
EP (2) | EP1000938A1 (ko) |
JP (1) | JPH07508747A (ko) |
KR (1) | KR950702545A (ko) |
CN (2) | CN1042532C (ko) |
AT (1) | ATE207470T1 (ko) |
AU (1) | AU678974B2 (ko) |
CA (1) | CA2139442A1 (ko) |
CZ (1) | CZ1095A3 (ko) |
DE (1) | DE69331010D1 (ko) |
FI (1) | FI950016A (ko) |
HU (1) | HUT71247A (ko) |
MX (1) | MX9303981A (ko) |
NO (2) | NO305318B1 (ko) |
NZ (1) | NZ253742A (ko) |
PL (2) | PL174610B1 (ko) |
RU (1) | RU2134686C1 (ko) |
SK (1) | SK695A3 (ko) |
WO (1) | WO1994001420A1 (ko) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311661D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9311644D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9315148D0 (en) * | 1993-07-22 | 1993-09-08 | Smithkline Beecham Plc | Novel compounds |
GB9326171D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
TR199500916A2 (tr) * | 1994-07-29 | 1996-06-21 | Smithkline Beecham Plc | Tipta kullanilmak üzere yeni bilesikler. |
WO1996004261A1 (en) * | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
ES2283064T3 (es) | 1997-06-18 | 2007-10-16 | Smithkline Beecham Plc | Tratamiento de diabetes con tiazolin-diona y sulfonilurea. |
US6265401B1 (en) | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
MXPA00004036A (es) * | 1997-10-27 | 2006-05-24 | Reddys Lab Ltd Dr | Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen.. |
US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
GB2380997B (en) * | 1997-10-27 | 2003-07-02 | Reddys Lab Ltd Dr | Novel aryl-oxysubstituted alkyl carboxylic acids; process for their preparation and pharmaceutical compositions containing them |
HUP0101110A3 (en) | 1997-10-27 | 2002-06-28 | Reddys Lab Ltd Dr | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
CN1280574A (zh) | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物 |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
US6444816B1 (en) | 1997-10-27 | 2002-09-03 | Dr. Reddy's Research Foundation | Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof |
US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
CN1208326C (zh) * | 1998-04-23 | 2005-06-29 | 雷迪实验室有限公司 | 杂环化合物及其在医药方面的应用、其制备方法及含有它们的药物组合物 |
SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
CN1230162C (zh) | 1998-11-12 | 2005-12-07 | 史密丝克莱恩比彻姆有限公司 | 改进释放胰岛素致敏剂和另一抗糖尿病药的药用组合物 |
AR023699A1 (es) | 1998-11-12 | 2002-09-04 | Smithkline Beecham Corp | Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica |
US7000106B2 (en) * | 1999-03-26 | 2006-02-14 | Siemens Communications, Inc. | Methods and apparatus for kernel mode encryption of computer telephony |
US6972294B1 (en) | 1999-04-20 | 2005-12-06 | Novo Nordisk, A/S | Compounds, their preparation and use |
CA2382966A1 (en) | 1999-08-27 | 2001-03-08 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
SE9904415D0 (sv) * | 1999-12-03 | 1999-12-03 | Astra Ab | New process |
CA2397828C (en) * | 2000-01-19 | 2007-09-04 | Cadila Healthcare Ltd. | Compounds having hypolipidemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
CN1396904A (zh) * | 2000-01-28 | 2003-02-12 | 诺沃挪第克公司 | 新颖的化合物、它们的制备和用途 |
US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
US6569901B2 (en) | 2000-01-28 | 2003-05-27 | Novo Nordisk A/S | Alkynyl-substituted propionic acid derivatives, their preparation and use |
US6509374B2 (en) | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
US6559335B2 (en) | 2000-09-22 | 2003-05-06 | Dr. Reddy's Laboratories Limited | Process for the preparation of 3-aryl-2-hydroxy propanoic acid |
TWI311133B (en) * | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
PT1392295E (pt) | 2001-05-15 | 2006-09-29 | Hoffmann La Roche | Derivados de oxazole substituidos por acidos carboxilicos para serem utilizados como activadores de rapp alfa e gama no tratamento de diabetes |
US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
US7371777B2 (en) | 2001-08-17 | 2008-05-13 | Eisai Co., Ltd. | Cyclic compound and PPAR agonist |
US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
AU2002351752A1 (en) | 2001-12-29 | 2003-07-30 | Novo Nordisk A/S | Combined use of a glp-1 compound and another drug for treating dyslipidemia |
US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
PT1537091E (pt) * | 2002-08-30 | 2010-11-11 | Hoffmann La Roche | Novos compostos de 2-ariltiazole como agonistas de ppar-alfa e de ppar-gama |
CA2494601C (en) | 2002-09-12 | 2009-09-29 | F. Hoffmann-La Roche Ag | N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
CA2505545C (en) | 2002-11-25 | 2011-06-07 | F. Hoffmann-La Roche Ag | Indolyl derivatives |
US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
US6653334B1 (en) | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
WO2004110998A1 (en) * | 2003-05-16 | 2004-12-23 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
US20050182125A1 (en) * | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
US20040248972A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Compounds and uses thereof |
CN101166725A (zh) * | 2005-02-25 | 2008-04-23 | 武田药品工业株式会社 | 吡啶基乙酸化合物 |
WO2008117982A1 (en) * | 2007-03-28 | 2008-10-02 | Crystal Genomics, Inc. | Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same |
JPWO2008139879A1 (ja) * | 2007-04-26 | 2010-07-29 | ファルマフロンティア株式会社 | G蛋白質共役型レセプター抑制剤および医薬 |
MX350611B (es) | 2011-01-31 | 2017-09-11 | Cadila Healthcare Ltd | Tratamiento para la lipodistrofia. |
US20160166539A1 (en) | 2013-04-22 | 2016-06-16 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
TW201636015A (zh) | 2013-07-05 | 2016-10-16 | 卡地拉保健有限公司 | 協同性組成物 |
IN2013MU02470A (ko) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
CN103467407B (zh) * | 2013-09-03 | 2015-04-22 | 浙江医药高等专科学校 | 四氮唑羧酸类化合物及其用途 |
CN103467409B (zh) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | 取代的四氮唑羧酸类化合物及其用途 |
CN103467408B (zh) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | 一类四氮唑羧酸类化合物及其用途 |
CN103467405B (zh) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | 一类四氮唑羧酸类化合物、其制备方法和用途 |
CN103467406B (zh) * | 2013-09-03 | 2014-12-17 | 浙江医药高等专科学校 | 卤素取代的四氮唑羧酸类化合物、其制备方法和用途 |
IN2013MU02905A (ko) | 2013-09-06 | 2015-07-03 | Cadila Healthcare Ltd | |
WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
WO2018104916A1 (en) | 2016-12-09 | 2018-06-14 | Cadila Healthcare Limited | Treatment for primary biliary cholangitis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5232925A (en) * | 1987-09-04 | 1993-08-03 | Beecham Group P.L.C. | Compounds |
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituierte Thiazolidindionderivate |
US5194443A (en) * | 1987-09-04 | 1993-03-16 | Beecham Group P.L.C. | Compounds |
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
GB9017218D0 (en) * | 1990-08-06 | 1990-09-19 | Beecham Group Plc | Novel compounds |
-
1993
- 1993-06-29 SK SK6-95A patent/SK695A3/sk unknown
- 1993-06-29 PL PL93307087A patent/PL174610B1/pl unknown
- 1993-06-29 RU RU94046169A patent/RU2134686C1/ru active
- 1993-06-29 AT AT93914841T patent/ATE207470T1/de not_active IP Right Cessation
- 1993-06-29 AU AU45068/93A patent/AU678974B2/en not_active Ceased
- 1993-06-29 CZ CZ9510A patent/CZ1095A3/cs unknown
- 1993-06-29 HU HU9500006A patent/HUT71247A/hu unknown
- 1993-06-29 EP EP99204395A patent/EP1000938A1/en not_active Withdrawn
- 1993-06-29 NZ NZ253742A patent/NZ253742A/en unknown
- 1993-06-29 WO PCT/GB1993/001363 patent/WO1994001420A1/en not_active Application Discontinuation
- 1993-06-29 CA CA002139442A patent/CA2139442A1/en not_active Abandoned
- 1993-06-29 EP EP93914841A patent/EP0648212B1/en not_active Expired - Lifetime
- 1993-06-29 DE DE69331010T patent/DE69331010D1/de not_active Expired - Lifetime
- 1993-06-29 JP JP6503071A patent/JPH07508747A/ja active Pending
- 1993-06-29 KR KR1019940704886A patent/KR950702545A/ko not_active Application Discontinuation
- 1993-06-29 US US08/360,755 patent/US6048883A/en not_active Expired - Fee Related
- 1993-06-29 PL PL93316129A patent/PL176885B1/pl unknown
- 1993-07-01 MX MX9303981A patent/MX9303981A/es not_active IP Right Cessation
- 1993-07-02 CN CN93109874A patent/CN1042532C/zh not_active Expired - Fee Related
-
1995
- 1995-01-02 NO NO950009A patent/NO305318B1/no not_active IP Right Cessation
- 1995-01-02 FI FI950016A patent/FI950016A/fi unknown
- 1995-06-02 US US08/458,335 patent/US5869495A/en not_active Expired - Fee Related
-
1998
- 1998-05-14 CN CN98108909A patent/CN1215724A/zh active Pending
-
1999
- 1999-01-19 NO NO990227A patent/NO990227D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO990227D0 (no) | 1999-01-19 |
HUT71247A (en) | 1995-11-28 |
JPH07508747A (ja) | 1995-09-28 |
MX9303981A (es) | 1994-04-29 |
US5869495A (en) | 1999-02-09 |
PL307087A1 (en) | 1995-05-02 |
NZ253742A (en) | 1997-06-24 |
PL174610B1 (pl) | 1998-08-31 |
ATE207470T1 (de) | 2001-11-15 |
KR950702545A (ko) | 1995-07-29 |
AU4506893A (en) | 1994-01-31 |
PL176885B1 (pl) | 1999-08-31 |
NO305318B1 (no) | 1999-05-10 |
US6048883A (en) | 2000-04-11 |
FI950016A0 (fi) | 1995-01-02 |
HU9500006D0 (en) | 1995-03-28 |
CN1042532C (zh) | 1999-03-17 |
NO950009L (no) | 1995-03-02 |
AU678974B2 (en) | 1997-06-19 |
EP0648212A1 (en) | 1995-04-19 |
NO950009D0 (no) | 1995-01-02 |
CN1215724A (zh) | 1999-05-05 |
RU94046169A (ru) | 1996-10-27 |
CZ1095A3 (en) | 1995-10-18 |
CA2139442A1 (en) | 1994-01-20 |
SK695A3 (en) | 1995-07-11 |
EP1000938A1 (en) | 2000-05-17 |
WO1994001420A1 (en) | 1994-01-20 |
EP0648212B1 (en) | 2001-10-24 |
DE69331010D1 (de) | 2001-11-29 |
CN1095716A (zh) | 1994-11-30 |
RU2134686C1 (ru) | 1999-08-20 |
NO990227L (no) | 1995-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI950016A (fi) | Heterosykliset yhdisteet lääkeaineena | |
DE3856378D1 (de) | Substituierte Thiazolidindionderivate | |
ATE102193T1 (de) | Thiazolidinedionederivate. | |
DE69016899D1 (de) | Thiazolidinedionederivate. | |
EP0356214A3 (en) | Thiazolidine dione derivatives | |
DK0695183T3 (da) | Anvendelse af thiazolidindioner til behandling af atherosklerose og spiseforstyrrelser | |
ATE34976T1 (de) | Arylcyclobutylalkylamine und ihre verwendung als antidepressive arzneimittel. | |
DE69625795D1 (de) | Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten | |
MX15697A (es) | Derivados heterotetraciclicos de lactama y procesopara su preparacion | |
MX9703112A (es) | Nitro-benzamidas utiles como agentes antiarritmicos. | |
TH17758A (th) | สารเคมี |